Preclinical combination therapy with gemcitabine and mechanisms of resistance

被引：0
|
作者：
Peters, GJ [1 ]
vanHaperen, VWTR [1 ]
Bergman, AM [1 ]
Veerman, G [1 ]
SmitskampWilms, E [1 ]
vanMoorsel, CJA [1 ]
Kuiper, CM [1 ]
Braakhuis, BJM [1 ]
机构：
[1] FREE UNIV AMSTERDAM HOSP,DEPT OTOLARYNGOL,NL-1007 MB AMSTERDAM,NETHERLANDS
来源：
SEMINARS IN ONCOLOGY | 1996年 / 23卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：16 / 24
页数：9
相关论文
共 50 条
  • [21] Combination gemcitabine and docetaxel therapy in advanced adenocarcinoma of the pancreas
    Sherman, WH
    Fine, RL
    ONCOLOGY, 2001, 60 (04) : 316 - 321
  • [22] Mechanisms of resistance to antiangiogenic therapy in preclinical models of head and neck squamous cell carcinoma (HNSCC)
    Gyanchandani, Rekha
    Grandis, Jennifer R.
    Kim, Seungwon
    CANCER RESEARCH, 2012, 72
  • [23] Recent Advances in Lipid-Based Nanosystems for Gemcitabine and Gemcitabine-Combination Therapy
    Habib, Saffiya
    Singh, Moganavelli
    NANOMATERIALS, 2021, 11 (03) : 1 - 12
  • [24] Preclinical studies for the combination of paclitaxel and curcumin in cancer therapy
    Wei, Yumeng
    Pu, Xinlin
    Zhao, Ling
    ONCOLOGY REPORTS, 2017, 37 (06) : 3159 - 3166
  • [25] Mechanisms of Acquired Resistance to Venetoclax in Preclinical AML Models
    Zhang, Qi
    Pan, Rongqing
    Han, Lina
    Shi, Ce
    Kurtz, Stephen E.
    Mu, Hong
    Ma, Helen
    Andreeff, Michael
    Leverson, Joel
    Tyner, Jeffrey W.
    Mi, Yingchang
    Konopleva, Marina
    BLOOD, 2015, 126 (23)
  • [26] Preclinical Support for Combination Therapy in the Treatment of Autoimmunity with Atacicept
    Ponce, Rafael
    TOXICOLOGIC PATHOLOGY, 2009, 37 (01) : 89 - 99
  • [27] TRANSLATIONAL PRECLINICAL PLATFORM FOR EVALUATION OF ANTIMALARIAL COMBINATION THERAPY
    Lafuente, Maria J.
    Sanz, Laura
    Leroy, Didier
    Haselden, John
    Javier Gamo, Francisco
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 97 (05): : 306 - 306
  • [28] Unraveling resistance mechanisms in combination therapy: A comprehensive review of recent advances and future directions
    Morales-Duran, Nami
    Leon-Buitimea, Angel
    Morones-Ramirez, Jose R.
    HELIYON, 2024, 10 (06)
  • [29] Significance of combination therapy of zoledronic acid and gemcitabine on pancreatic cancer
    Zhao, Ming
    Tominaga, Yohei
    Ohuchida, Kenoki
    Mizumoto, Kazuhiro
    Cui, Lin
    Kozono, Shingo
    Fujita, Hayato
    Maeyama, Ryo
    Toma, Hiroki
    Tanaka, Masao
    CANCER SCIENCE, 2012, 103 (01): : 58 - 66
  • [30] Gemcitabine and paclitaxel combination therapy in transitional cell carcinoma of the urothelium
    Meluch, A. A.
    Burris, H. S.
    Greco, F. A.
    Hainsworth, J. D.
    EUROPEAN JOURNAL OF CANCER, 2000, 36 : S30 - S33
12345